bioMérieux Bestowed 2007 Frost & Sullivan European Healthcare-Associated Infection Control Technology Leadership Award
bioMérieux was rewarded for its committment toward healthcare-associated infection control
The global growth consulting company Frost & Sullivan conferred this award to bioMérieux in recognition of its unparalleled leadership and commitment toward healthcare-associated infection control and its pioneering and extensive work in this field.
Healthcare-associated infections (HAI) are among bioMérieux’s six strategic disease areas. It is the company’s objective to offer a complete and integrated solution for these infections, with bioMérieux's product offerings spanning the range from manual and culture-based methods to automated and molecular techniques.
An award for innovation...
Frost & Sullivan’s Technology Leadership Award is bestowed upon a company that has pioneered the development and introduction of an innovative technology into the market; a technology that has either impacted or has the potential to impact several market sectors.
... for contribution to the industry...
This award recognises a company’s successful technology development that is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture.
... and for the broadcasting of technology
It also recognizes the leadership of the company in the successful promotion of the technology and its continuing impact in technology commercialisation.
Further info
Website: www.biomerieux.com
